Abstract
Background: Arctostaphylosuva-ursi(AUU) being rich in polyphenols and arbutin is known to have promising biological activities and can be a potential candidate as a cosmaceutical. Ethosomes encourage the formation of lamellar-shaped vesicles with improved solubility and entrapment of many drugs including plant extracts.
Objective: The objective of this work was to develop an optimized nanostructured ethosomal gel formulation loaded with AUU extract and evaluated for skin rejuvenation and depigmentation.
Methods: AUU extract was tested for phenolic and flavonoid content, radical scavenging potential, reducing power activity, and in-vitro SPF (sun protection factor) estimation. AUU loaded 12 formulations were prepared and characterized by SEM (Scanning Electron Microscopy), vesicular size, zeta potential, and Entrapment Efficiency (%EE). The optimized formulation was subjected to noninvasive in-vivo investigations after incorporating it into the gel system and ensuring its stability and skin permeation.
Results: Ethosomal vesicles were spherical in shape and Zeta size, zeta potential, PDI (Polydispersity Index), percentages of EE and in-vitro skin permeation of optimized formulation (F3) were found to be 114.7nm, -18.9mV, 0.492, 97.51±0.023%, and 79.88±0.013% respectively. AUU loaded ethosomal gel formulation was stable physicochemically and exhibited non-Newtonian behavior rheologically. Moreover, it significantly reduced skin erythema, melanin as well as sebum level and improved skin hydration and elasticity.
Conclusion: A stable AUU based ethosomal gel formulation could be a better vehicle for phytoextracts than conventional formulations for cosmeceutical applications such as for skin rejuvenation and depigmentation.
Keywords: Arctostaphylos uva-ursi, ethosomes, cosmeceutical, sun protection factor, non-invasive in-vivo study, arbutin.
Graphical Abstract
[http://dx.doi.org/10.3390/pharmaceutics9040048] [PMID: 29065483]
[http://dx.doi.org/10.3390/medicines5020026] [PMID: 29565294]
[http://dx.doi.org/10.1111/j.1600-0625.2008.00786.x] [PMID: 19043850]
[http://dx.doi.org/10.1111/j.1751-1097.2007.00226.x] [PMID: 18435612]
[http://dx.doi.org/10.1016/j.phymed.2011.10.003] [PMID: 22115797]
[http://dx.doi.org/10.1166/jbn.2010.1152] [PMID: 21329048]
[http://dx.doi.org/10.5138/ijdd.2010.0975.0215.02016]
[http://dx.doi.org/10.4103/0110-5558.72415] [PMID: 22247858]
[http://dx.doi.org/10.1016/S0168-3659(99)00222-9] [PMID: 10699298]
[http://dx.doi.org/10.3390/molecules15096168] [PMID: 20877214]
[http://dx.doi.org/10.1016/j.talanta.2018.12.057] [PMID: 30683397]
[http://dx.doi.org/10.1016/S0740-0020(02)00107-7]
[http://dx.doi.org/10.3390/plants9091250] [PMID: 32971908]
[http://dx.doi.org/10.3390/antiox5020011] [PMID: 27043639]
[http://dx.doi.org/10.1016/j.bmc.2010.05.045] [PMID: 20584613]
[http://dx.doi.org/10.1016/j.jfca.2009.04.001]
[http://dx.doi.org/10.1016/S0308-8146(98)00102-2]
[http://dx.doi.org/10.1016/j.jfda.2013.11.001] [PMID: 28911418]
[http://dx.doi.org/10.1590/S1516-93322004000300014]
[http://dx.doi.org/10.1111/j.1751-1097.1979.tb07090.x] [PMID: 441130]
[http://dx.doi.org/10.1208/s12249-019-1556-z] [PMID: 31858305]
[http://dx.doi.org/10.1007/s10600-018-2323-1]
[http://dx.doi.org/10.1208/s12249-011-9624-z] [PMID: 21538212]
[http://dx.doi.org/10.1007/s11814-012-0171-4]
[http://dx.doi.org/10.5530/jyp.2017.9.67]
[PMID: 18649702]
[http://dx.doi.org/10.1016/j.bjp.2015.07.013]
[http://dx.doi.org/10.1002/pca.1142] [PMID: 19609883] ; b) Liu Y-S, Wen C-F, Yang Y-M. Development of ethosome-like catanionic vesicles for dermal drug delivery. J Taiwan Inst Chem Eng 2012; 43(6): 830-8.
[http://dx.doi.org/10.1016/j.jtice.2012.06.008]
[http://dx.doi.org/10.1016/j.ijpharm.2006.12.005] [PMID: 17222523]
[http://dx.doi.org/10.1016/j.ijpharm.2005.02.021] [PMID: 15896932]
[http://dx.doi.org/10.1016/j.ijpharm.2019.04.001] [PMID: 30951860]
[http://dx.doi.org/10.3390/pharmaceutics10020057] [PMID: 29783687]
[http://dx.doi.org/10.2147/IJN.S86186] [PMID: 26425085]
[http://dx.doi.org/10.5812/jjm.57875]
[http://dx.doi.org/10.1016/j.jare.2016.03.003] [PMID: 27222750]
[http://dx.doi.org/10.1016/j.colsurfa.2013.01.003]
[http://dx.doi.org/10.1016/j.jpba.2004.10.030] [PMID: 15708669]
[http://dx.doi.org/10.1016/S0378-5173(02)00462-3] [PMID: 12480271]
[http://dx.doi.org/10.3109/03639045.2015.1132227] [PMID: 26727599]
[http://dx.doi.org/10.1016/S0142-9612(01)00052-7] [PMID: 11575480]
[http://dx.doi.org/10.5530/pj.2019.11.193]
[http://dx.doi.org/10.1002/adv.21546]
[http://dx.doi.org/10.1208/s12249-018-1279-6] [PMID: 30631984]
[http://dx.doi.org/10.3390/pharmaceutics12121181] [PMID: 33291738]
[http://dx.doi.org/10.3390/ph14050467] [PMID: 34063413]
[http://dx.doi.org/10.1016/j.jtv.2016.03.002] [PMID: 27020864]
[http://dx.doi.org/10.1111/php.13113] [PMID: 31066905]
[http://dx.doi.org/10.3390/molecules22091480] [PMID: 28872626] ; bCouteau C, Coiffard L. Overview of skin whitening agents: Drugs and cosmetic products. Cosmetics 2016; 3(3): 27.
[http://dx.doi.org/10.3390/cosmetics3030027]
[http://dx.doi.org/10.1016/j.tibs.2009.08.001] [PMID: 19726197]
[http://dx.doi.org/10.1155/2015/853846] [PMID: 25709710]